Hydrochloric Acid

Hydrochloric Acid

SCHEMBL158635

Cn1sc(Cl)cc1=O.[Ca+2].[Cl-].[Cl-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 11/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA9 Q16790 1/20 0.50
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11190142 1.00 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
Hydrochloric Acid SCHEMBL410386 0.95
Hydrochloric Acid SCHEMBL11708723 0.95 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
Hydrochloric Acid SCHEMBL11186626 0.95 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
Hydrochloric Acid SCHEMBL11188349 0.95 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
Hydrochloric Acid SCHEMBL11710311 0.95 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
Hydrochloric Acid SCHEMBL155941 0.95 KAT2B (0.50) KAT2BCA12CA1CA9GSK3A
SCHEMBL20686 0.95
SCHEMBL7976030 0.93
Ammonia Solution, Strong SCHEMBL7939400 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180362214-A1 LINER WITH ANTI-MICROBIAL AND/OR ANTI-FUNGAL AGENT BROADWAY HOLDINGS IV, LLC 2018-12-20 US claimed
US-20100175796-A1 Anti fungal and anti-microbial protection for storage items and protective covers BROADWAY HOLDINGS IV, LLC 2010-07-15 US claimed
US-3975155-A Quantitative method for detecting 3-isothiazolones ROHM AND HAAS COMPANY (US) 1976-08-17 US claimed
US-3947581-A SLIMICIDES BETZ LABORATORIES, INC. (US) 1976-03-30 US claimed
EP-4722292-A1 YELLOW-AZO-PIGMENT-CONTAINING COLORING COMPOSITION AND METHOD FOR PRODUCING SAME Otsuka Chemical Co., Ltd. (JP) 2026-04-08 EP disclosed
US-12577421-B2 Inkjet ink, ink set, ink medium set, and printing medium NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
US-12552952-B2 Inkjet ink, inkjet recording method, ink set, ink medium set, and print medium NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-02-17 US disclosed
EP-4692255-A1 AQUEOUS INK COMPOSITION, INK SET, AND METHOD FOR PRODUCING INKJET-PRINTED MATTER Nippon Kayaku Kabushiki Kaisha (JP) 2026-02-11 EP disclosed
EP-4614621-A1 CARBON MATERIAL DISPERSION SOLUTION, AND SLURRY COMPOSITION FOR SECONDARY BATTERY NEGATIVE ELECTRODES IN WHICH SAME IS USED MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2025-09-10 EP disclosed
EP-4570873-A1 INKJET INK, INK SET, INK MEDIUM SET, AND PRINTING MEDIUM Nippon Kayaku Kabushiki Kaisha (JP) 2025-06-18 EP disclosed
US-20250185669-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2025-06-12 US disclosed
US-20250179318-A1 INKJET INK NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2025-06-05 US disclosed
US-3975155-A Quantitative method for detecting 3-isothiazolones ROHM AND HAAS COMPANY (US) 1976-08-17 US disclosed
US-3947581-A SLIMICIDES BETZ LABORATORIES, INC. (US) 1976-03-30 US disclosed
US-3947581-A SLIMICIDES BETZ LABORATORIES, INC. (US) 1976-03-30 US disclosed
US-3929561-A Synergistic compositions containing bis (trichloromethyl) sulfone and their use BETZ LABORATORIES 1975-12-30 US disclosed
US-3929563-A Synergistic compositions containing N (2 nitrobutyl) morpholine and their use BETZ LABORATORIES 1975-12-30 US disclosed
US-3929562-A Synergistic compositions containing 2,2-dibromo-3-nitriloproprionamide and their use BETZ LABORATORIES 1975-12-30 US disclosed
US-3908030-A Slime control compositions and their use BETZ LABORATORIES 1975-09-23 US disclosed
US-3879559-A Slime control compositions and their use BETZ LABORATORIES 1975-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552952-B2 Inkjet ink, inkjet recording method, ink set, ink medium set, and print medium BMP1, SMAD2, SMAD3 KAT2B 2211/4885CA12 1314/4885CA1 1404/4885
US-12577421-B2 Inkjet ink, ink set, ink medium set, and printing medium MITF, EYA3, EYA2 KAT2B 3710/4885CA12 3268/4885CA1 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.